Form 4: HeartBeam Director Ortigas-Wedekind Reports Acquisition of Common Stock and Stock Units
SEC Form 4
Director Marga Ortigas-Wedekind reports acquiring common stock and stock units in HeartBeam, Inc.
Summary
- Marga Ortigas-Wedekind, a director of HeartBeam, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 12, 2024, Ortigas-Wedekind acquired 33,185 shares of common stock at $0.
- Following the transaction, Ortigas-Wedekind directly owns 112,293 shares of common stock and indirectly owns 16,824 shares through the Wedekind Living Trust.
- Ortigas-Wedekind also holds warrants to purchase 9,000 shares at $6, options to purchase 27,272 shares at $0.28, and options to purchase 16,363 shares at $2.5.
- The reported securities also include restricted stock units (RSUs) that represent a contingent right to receive one share of common stock of the Issuer.
- 100% of the RSUs shall vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares suggests confidence, but it's a routine filing.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The reported transactions provide shareholders with insights into the director's investment activities and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 11/11/2021 | Date of warrant grant with an exercise price of $6. |
| 05/12/2020 | Date of grant for options to purchase 27,272 shares at $0.28, with vesting starting on this date. |
| 07/15/2021 | Date of grant for options to purchase 16,363 shares at $2.5, with vesting starting on this date. |
| 06/12/2024 | Date of the reported transaction where 33,185 shares of common stock were acquired. |
| 06/12/2025 | Date when 100% of the RSUs shall vest, contingent on continued service as an Outside Director. |
| 11/11/2026 | Expiration date of warrants granted on 11/11/2021. |
| 05/12/2030 | Expiration date of options to purchase 27,272 shares at $0.28. |
| 06/15/2031 | Expiration date of options to purchase 16,363 shares at $2.5. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.